Lipogems® Announces 140 Independent Peer Reviewed Publications with 5 Years of Follow up in Orthopaedics

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • We are grateful for these researchers seeing benefit in the previous evidence that has shown the power of the Lipogems MicroFat and that they have taken on the task to independently advance evidence-based medicine which benefits patients in orthopaedics, colorectal surgery, and general surgery,”.
  • As a science driven company, we are proud to see that 98% of the 140 peer-reviewed publications that studied the Lipogems device and tissue are independent studies from well-respected academic, military, and private practice institutions,”.
  • Lipogems has been used in more than 60,000 procedures worldwide and is currently FDA cleared for use in the US for general applications in orthopaedics, arthroscopy, and nine other specialties since 2014.

Lipogems announced today that there are now 140 peer reviewed publications supporting Lipogems’ MicroFat with 5 years of follow up in orthopaedics.

“Lipogems has sought out to help patients that have tried conservative options and other therapies with limited relief. As a science driven company, we are proud to see that 98% of the 140 peer-reviewed publications that studied the Lipogems device and tissue are independent studies from well-respected academic, military, and private practice institutions,” said Giorgio Ninzoli, President of Lipogems International. “The gold standard for evidence is 1 year follow up and we are excited to report 5 years follow up with positive results after a single injection of MicroFat.”

Lipogems has been used in more than 60,000 procedures worldwide and is currently FDA cleared for use in the US for general applications in orthopaedics, arthroscopy, and nine other specialties since 2014. Lipogems partners with leading institutions to keep their patients in their care continuum, offering physicians a compliant option for both surgical and non-operative applications.

“Many physicians have patients that have exhausted other therapies and they don’t have many options to help them. We are grateful for these researchers seeing benefit in the previous evidence that has shown the power of the Lipogems MicroFat and that they have taken on the task to independently advance evidence-based medicine which benefits patients in orthopaedics, colorectal surgery, and general surgery,” Said Carl Llewellyn, President, Lipogems USA.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Phase 1 Study Measuring Dosing Effects of LSD Completed: Results of Study Will Aid In Planning a Phase 2 Study

The study was conducted in partnership with University Hospital Basel's Liechti Lab.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

NuVision ICE Catheter: Positive Results From First-in-human Feasibility Study Reported At 2020 TCT Conference

"Initial clinical experience of the NuVision ICE Catheter supports safe and effective use with all primary and secondary safety and performance endpoints met and zero adverse events reported," commented Dr. Latib.

By using this website you agree to accept Medical Device News Magazine Privacy Policy